000 05557cam a2200421Ii 4500
001 96199
003 ES-MaUEC
005 20230102112743.0
006 m o d
007 cr cnu|||unuuu
008 170619s2017 sz o 000 0 eng d
020 _a3319559508
_q(electronic bk.)
020 _a9783319559506
_q(electronic bk.)
020 _z3319559494
020 _z9783319559490
040 _aN$T
_cN$T
_dN$T
_dEBLCP
_dYDX
_dGW5XE
_dOCLCF
_dUAB
_dAZU
_dUPM
_dKOS
_dOCLCO
_dMERER
_dESU
_dEZ9
_dOCLCQ
_dCOO
_dOCLCQ
_dIOG
_dOCLCO
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRC271.R3
_b2017 EB
100 1 _aSourati, Ainaz,
_eautor
245 1 0 _aAcute side effects of radiation therapy :
_ba guide to management
_cAinaz Sourati, Ahmad Ameri, Mona Malekzadeh.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
505 0 _aForeword; Introduction; 1: Radiation Dermatitis; 1.1 Mechanism; 1.2 Timing; 1.3 Sign and Symptoms; 1.4 Scoring; 1.5 Risk Factors; 1.5.1 Treatment-Related Factors Including; 1.5.2 Patient-Related Factors Include; 1.6 Diagnosis; 1.7 Prevention; 1.7.1 General Measures; 1.7.2 Intensity-Modulated Radiation Therapy (IMRT); 1.7.3 Low-Level Laser Therapy; 1.7.4 Amifostine; 1.7.5 Ascorbic Acid; 1.7.6 Oral Zinc; 1.7.7 Silver Leaf Dressing; 1.7.8 MAS065D; 1.7.9 Soft Dressing or Barrier Film; 1.7.10 Hyaluronic Acid; 1.7.11 Trolamine; 1.7.12 Topical Sucralfate; 1.7.13 Theta Cream.
505 8 _a1.7.14 Dexpanthenol (Provitamin B5)1.7.15 Calendula; 1.7.16 Pentoxifylline; 1.7.17 Aloe Vera; 1.7.18 Deodorant; 1.7.19 Laughter Therapy; 1.8 Management; 1.8.1 Grade 1 Dermatitis; 1.8.2 Grade 2-3 Dermatitis; 1.8.3 Grade 4 Dermatitis; References; 2: Hair Loss; 2.1 Mechanism; 2.2 Timing; 2.2.1 Risk Factors; 2.2.2 Symptoms; 2.3 Scoring; 2.4 Prevention; 2.5 Management; References; 3: Radiation Brain Injury; 3.1 Mechanism; 3.2 Timing; 3.3 Risk Factors; 3.3.1 Treatment-Related Factors; 3.3.2 Patient-Related Factor; 3.4 Symptoms; 3.5 Diagnosis; 3.6 Scoring.
505 8 _a3.7 Prevention and Management3.7.1 Dexamethasone Prescription; References; 4: Radiation Orbital Toxicity; 4.1 Blepharitis and Eyelid Dermatitis; 4.2 Eyelash Loss; 4.3 Conjunctivitis; 4.4 Xerophthalmia; 4.5 Corneal Toxicity; 4.5.1 Treatment; 4.5.1.1 Topical Lubricants (e.g., Ophthalmic Ointment); 4.5.1.2 Analgesics; 4.5.1.3 Ophthalmologist Consult; 4.6 Iris Toxicity; References; 5: Ear Toxicity; 5.1 Mechanism; 5.2 Timing; 5.3 Risk Factors; 5.4 Symptoms and Diagnosis; 5.5 Scoring; 5.6 Management; References; 6: Oral Mucositis; 6.1 Mechanism; 6.2 Timing; 6.3 Risk Factors.
505 8 _a6.3.1 Tumor Site6.3.2 Concomitant Systemic Therapy; 6.3.3 Radiation Dose; 6.3.4 Radiation Fractionation Schedule; 6.3.5 Patient-Related Factors; 6.4 Symptoms; 6.5 Scoring; 6.6 Prevention; 6.6.1 Prophylactic Interventions; 6.6.2 Prophylactic Intervention Under Evaluation; 6.7 Management; 6.7.1 Patient Assessment; 6.7.2 Mouth Care; 6.7.3 Management of Oral Pain; 6.7.3.1 Benzydamine Mouth Wash; 6.7.3.2 Doxepin; 6.7.3.3 Magic Mouthwash; 6.7.3.4 Gelclair; 6.7.3.5 CAM2028; 6.7.3.6 MF 5232; 6.7.3.7 Acetylcysteine; 6.7.3.8 Opiates; 6.7.3.9 Corticosteroids; 6.7.3.10 Gabapentin.
505 8 _a6.7.3.11 Other Analgesic Agents6.7.3.12 Sucralfate; 6.7.3.13 Phenytoin Mouthwash; 6.7.3.14 Low-Level Laser Therapy; 6.7.4 Antifungals; 6.7.5 Antivirals; 6.7.6 Feeding Tube/Nutritional Support; References; 7: Xerostomia; 7.1 Mechanism; 7.2 Timing; 7.3 Risk Factors; 7.4 Symptoms; 7.5 Diagnosis; 7.6 Scoring; 7.7 Prevention; 7.7.1 Amifostin; 7.7.1.1 Prescription; 7.7.1.2 Contraindications; 7.7.1.3 Advers effects; 7.7.2 IMRT; 7.7.3 Submandibular gland transfer; 7.7.4 Pilocarpine; 7.7.4.1 Prescription; 7.7.4.2 Contraindications; 7.7.5 Acupuncture; 7.8 Management.
520 3 _aThis book provides clear guidance on how to manage a wide range of side effects frequently encountered when treating patients with radiation therapy. For each potential side effect, incidence, mechanism, symptoms, and grading are carefully described. All aspects of management are addressed, drawing on the latest available evidence and highlighting key details of importance in clinical routine. The introduction of new radiation therapy techniques such as 3D conformal radiation therapy, intensity-modulated radiation therapy, and image-guided radiation therapy has reduced normal tissue doses and, accordingly, treatment complications. Nevertheless, a significant percentage of patients still experience acute side effects, in part because the threshold doses for these toxicities are typically lower than those for late effects. Acute toxicities may lead to interruption of treatment and be associated with an increase in late damage. A swift and effective response is therefore essential. This book will enable the reader to provide effective care for each side effect, thereby improving patient compliance with treatment and treatment outcomes.
650 7 _aCancer
_xNursing.
_2fast
_0(OCoLC)fst00845400
_9139308
_0comprobar BNE19900970859
700 1 _aAmeri, Ahmad,
_eautor
700 1 _aMalekzadeh, Mona,
_eautor
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-55950-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c96199
_d96199
_x1